Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

Global Biobanking Market CAGR Growth of 8% by 2019 - Trends, Technologies & Opportunities Report 2016-2020 - Key Vendors: Askion, B&C Group, BioBank

DUBLIN, March 7, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/wvpzkt/global_biobanking) has announced the addition of the "Global Biobanking Market 2016-2020" report to their offering.

This report predicts the global biobanking market to grow steadily at a CAGR of approximately 8% during the forecast period.

Commenting on the report, an analyst from Technavios team said: The in-house sampling testing and storage solutions can reduce the overall processing time and costs for manufacturers. A contract testing laboratory can take approximately three days for sampling and providing results, whereas in-house testing can reduce that time to 30 minutes. This process will decrease the cost per sample by nearly 40%. Most manufacturers perform in-house analytical testing to avail quick results.

According to the report, automating biobanking workflow will benefit biobanks by maintaining integrity and quality in long-term samples, minimizing manual errors, improving the workflow efficiency, and enabling long-term cost-effectiveness. Automation minimizes manual errors such as mislabeling or inaccurate sample barcoding and improves the technical efficiency. Further, it plays a vital role in blood fractionation, DNA extraction, labeling, and capping techniques.

Questions Answered:

  • What will the market size and the growth rate be in 2020
  • What are the key factors driving the global biobanking market
  • What are the key Market trends impacting the growth of the global biobanking market
  • What are the challenges to market growth
  • Who are the key vendors in this market space

Companies Mentioned:

  • Beckman Coulter
  • Tecan
  • Thermo Fischer Scientific
  • Askion GmBH
  • B&C Group
  • BioBank
  • BioCryo
  • BioRep SRL
  • BioStorage Technologies
  • Bluechip
  • Brooks Life Science Systems
  • Cryo Bio System
  • CryoXtract
  • DNA Genotek
  • Excilone
  • Fluidx
  • Indivumed
  • LVL Technologies
  • Micronic
  • Promega
  • QIAGEN
  • RURO
  • Seralab
  • SOL Group
  • Tissue Solutions
  • Trans-Hit Biomarkers
  • Wildcat Laboratory Solutions

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Biobanks: An overview

PART 06: Storage conditions for samples

PART 07: Market landscape

PART 08: Biobank funding and financial sustainability

PART 09: Harmonization of biobanking

PART 10: Market segmentation by product

PART 11: Market segmentation by sample type

PART 12: Geographical segmentation

PART 13: Market drivers

PART 14: Impact of drivers

PART 15: Market challenges

PART 16: Impact of drivers and challenges

PART 17: Market trends

PART 18: Vendor landscape

PART 19: Appendix

PART 20: About the Author

For more information visit http://www.researchandmarkets.com/research/wvpzkt/global_biobanking

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.